Snyder to Drive Financing for Spin-Out of Clinical-Stage Drug Programs GEORGETOWN, Texas–(BUSINESS WIRE)–September 24, 2020– DisperSol Technologies LLC announced today that its Board of Directors has appointed David S. Snyder as its Chief Financial Officer effective October 1, 2020. “David Snyder is a highly accomplished pharmaceutical finance executive with extensive experience in managing the finances […]